Navigation Links
Drinking in excess associated with increased risk for metabolic syndrome
Date:7/30/2008

Those who drink in excess of the U.S. Dietary Guidelines (i.e., men who usually drink more than two drinks per day or women who usually drink more than one drink per day) or those who binge drink are at increased risk for the metabolic syndrome, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

The metabolic syndrome consists of a series of risk factors and conditions that are strongly related to cardiovascular disease, the leading cause of death in the United States. These conditions include obesity, high blood pressure, and diabetes.

"These findings are significant because the National Health and Nutrition Examination Survey shows 58 percent of all current drinkers in the United States reported usual alcohol consumption that exceeded the Dietary Guidelines, and 52 percent of all current drinkers reported at least one episode of binge drinking in the past year," said Amy Fan, M.D., Ph.D., of the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC), in Atlanta, Ga., and lead author of the study. "Most people who consume alcohol in the United States drink in ways that may increase their risk of the metabolic syndrome and related conditions."

For this study, Dr. Fan and other researchers evaluated data from 1,529 participants of the 1999-2002 National Health and Nutrition Examination Survey. They restricted their analysis to current drinkers (participants who consumed at least 12 alcoholic drinks in 12 months) aged 20 to 84 years. The survey included both an interview and a physical examination that included a blood test. Measures of alcohol consumption included usual quantity consumed, drinking frequency, and frequency of binge drinking.

"Since more than half of current drinkers in our study drank in excess of the Dietary Guidelines limits and reported binge drinking, prevent
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Hurricane preparedness survey: Worries about drinking water and medical care
2. Research Finds Causal Link Between Ending Drinking, Depression
3. Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration
4. Binge drinking tied to conditions in the college environment
5. Tough Underage Drinking Laws Saving Lives
6. Pediatrics review of underage drinking prevention programs led by Iowa State researcher
7. Binge drinking due to copying behavior
8. Hazardous Drinking More Common Than Thought
9. Boosting Brain Protein Quickly Cut Excessive Drinking
10. New Treatment Shows Promise for Excessive Drinking
11. New Jersey Coalition Calls for Investigation of Private Wells to Protect Families from PFOA in Drinking Water
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 1CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3